Wissenschaftliche Publikationen 

Publikationsliste seit 2008

Originalarbeiten

2008

May M, Kalisch R, Hoschke B, Juretzek T, Wagenlehner F, Brookman-Amissah S, Spivak I, Braun KP, Bär W, Helke C. Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance? Urologe A. 2008 Jul;47(7):846-52. German;

Buse S,  Gilfrich C, Haferkamp A, Hohenfellner M : En Bloc ligation of the renal vascular pedicle during laparoscopic nephrectomy,  BJU Int. 2008 Apr;101(7):878-82.

Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, Djakovic N, Pahernik S, Hohenfellner M.: Vaporization of prostates of >/=80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.  BJU Int. 2008 Aug;102(3):322-7.

Gunia S, Fritzsche F, May M, Liebe D, Koch S. Do different disorders in cell cycle regulation account for different biological behavior of urothelial and sinonasal inverted papillomas?
Pathobiology. 2008;75(1):34-41. Epub 2008 Mar 11;

Pfitzenmaier J, Gilfrich C, Haferkamp A, Buse S, Hohenfellner M.: Change of Ureteral Submucosal Anti-reflux Implantation into an Intussuscepted Ileal Nipple Valve as Reflux Protection in Ureterosigmoidostomy.  Urology. 2008 Jul;72(1):192-5.

Brookman-Amissah S, Kendel F, Spivak I, Pflanz S, Roigas J, Klotz T, May M.Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma. BJU Int. 2008 Nov 25. [Epub ahead of print];

Weber A, Kristiansen I, Johannsen M, Oelrich B, Scholmann K, Gunia S, May M, Meyer HA, Behnke S, Moch H, Kristiansen G.The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer. 2008 Dec 16;8:369.

May M, Brookman-Amissah S, Roigas J, Gilfrich C., Pflanz S, Hoschke B, Gunia S: Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view;  Urologic Oncology: Seminars and Original Investigations 2008 Sep

Gunia S, Albrecht K, Koch S, Herrmann T, Ecke T, Loy V, Linke J, Siegsmund M, May M. Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability.
World J Urol. 2008 Jun;26(3):243-50. Epub 2008 Apr 5.

2009

Pfitzenmaier J, Pritsch M, Haferkamp A, Jakobi H, Fritsch F, Gilfrich C, Djakovic N, Buse S, Pahernik S, Hohenfellner M: Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population? BJU Int. 2009 Apr;103(7):877-82.

Djakovic N, Wagener N, Adams J, Gilfrich C,  Haferkamp A, Pfitzenmaier J, Toenshoff B, Schmidt J. Hohenfellner M: Intestinal reconstruction of the lower urinary tract as a prerequisite for renal transplantation;  BJU Int. 2008 Dec 2

Braun KP, May M, Grassmel Y, Führer S, Hoschke B, Braun V.The general practitioner's part in the initiation of diagnostic procedures in prostate cancer. Aktuelle Urol. 2008 Mar;39(2):141-6. German.

Gunia S, May M, Scholmann K, Störkel S, Hoschke B, Koch S, Dietel M, Kristiansen G. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Arch. 2008 Aug;453(2):165-70. Epub 2008 Jul 22.

Buse S, Gilfrich C, Hatiboglu G, Huber J, Bedke J, Pfitzenmaier J, Haferkamp A, Hohenfellner M.: Impact of preoperative haemoglobin concentrations on the efficiency of KTP-laser vaporization of the prostate.  World J Urol. 2009 Jan 15.

May M, Brookman-Amissah S, Roigas J, Hartmann A, Störkel S, Kristiansen G, Gilfrich C, Borchardt R, Hoschke B, Kaufmann O, Gunia S.: Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications. Eur Urol. 2009 Mar 31

May M, Brookman-Amissah S, Hoschke B, Gilfrich C, Braun KP, Kendel F.: Post-Void Residual Urine as a Predictor of Urinary Tract Infection-Is There a Cutoff Value in Asymptomatic Men? J Urol. 2009 Apr 15. [Epub ahead of print]

May M, Kendel F, Hoschke B, Gilfrich C, Kiessig S, Pflanz S, Seidel M, Brookman- Amissah S.: Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma : Overall survival analysis with a follow-up period in excess of more than 10 years; Urologe A. 2009 Jun 28. [Epub ahead of print]

Brookman-Amissah S, May M, Albrecht K, Herrmann T, Roigas J, Gilfrich CP, Pflanz S, Gunia S.: Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer. World J Urol. 2009 May 29. [Epub ahead of print]

May M, Brookman-Amissah S, Kendel F, Knoll N, Roigas J, Hoschke B, Miller K, Gilfrich C, Pflanz S, Gralla O.: Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma. Int J Urol. 2009 May 13. [Epub ahead of print]

 Rud O, Krause FS, Engehausen DG, May M, Gilfrich C.: Value of Radical Oncological Surgery in Bilateral Synchronous Renal Cell Cancer and Coincidental Simultaneous Prostate Cancer.  Aktuelle Urol. 2009 Jul 14. [Epub ahead of print]

Rud O, May M, Brookman-Amissah S, Moersler J, Greiner A, Gilfrich C.:  Retroperitoneal bronchogenic cyst treated by laparoscopic surgery.  Chirurg. 2009 Oct 8. [Epub ahead of print]

May M, Brookman-May S, Hoschke B, Gilfrich C, Kendel F, Baxmann S, Wittke S, Kiessig ST, Miller K, Johannsen M. Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.  Cancer Immunol Immunother. 2009 Oct 30. [Epub ahead of print]

2010

May M, Brookman-May S, Lebentrau S, Gilfrich C, Loy V, Theissig F, Roigas J, hke B, Burger M, Miller K. Concordance of the Gleason Score in Prostate Multibiopsy and Definitive Histology. Aktuelle Urol. 2010 Mar 22. [Epub ahead of print]

Brookman-May S, May M, Gilfrich C, Wieland WF, Burger M.: Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma? Rev Anticancer Ther. 2010 Jun;10(6):813-23.PMID: 20553207 [PubMed - in process]

Rud O, May M, Brookman-May S, Mörsler J, Rotter M, Gilfrich C.: Abscess-forming retroperitoneal actinomycosis after urogynaecological surgery. Urologe A. 2010 Jul 15. [Epub ahead of print] German. PMID: 20628866                  

Brookman-May S, Burger M, Hoschke B, Wieland WF, Kendel F, Gilfrich C, Braun KP, May M.: Association between residual urinary volume and urinary tract infection : Prospective trial in 225 male patients. Urologe A. 2010 Sep;49(9):1163-8. German

Rud O, Mörsler J, Peter J, May M, Gilfrich C.: A Non-Abscess-Forming Inflammation of the Corpora Cavernosa in a Diabetic Patient;  Aktuelle Urol. 2010 Sep;41(5):323-325. Epub 2010 Sep 7.

May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Bastian PJ.: Patients with bladder cancer in clinical stage T2 : Survival benefit and downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens. Urologe A. 2010 Oct 6. [Epub ahead of print]

Brookman-May S, May M, Wieland WF, Lebentrau S, Gunia S, Koch S, Gilfrich C, Roigas J, Hoschke B, Burger M. Should we abstain from Gleason score 2-4 in the diagnosis of prostate cancer? Results of a German multicentre study.  World J Urol. 2010 Dec 30. [Epub ahead of print]

2011

May M, Brookman-May S, Weißbach L, Herbst H, Gilfrich C, Papadopoulos T, Roigas J, Hofstädter F, Wieland WF, Burger M. Solitary mm) apical positive surgical margins are related to biochemical?and small (?3 recurrence after radical prostatectomy. Int J Urol. 2011 Feb 22. doi: 10.1111/j.1442-2042.2011.02736.x. [Epub ahead  of print]

May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A,  Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ.: Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study : Are we able to adequately predict locally advanced tumour stages before surgery?] Urologe A. 2011 Feb 23. [Epub ahead of print]

May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ. Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder : Survival analysis of a German multi-centre study                        after curative treatment of urothelial carcinoma of the bladder.] Urologe A. 2011 Feb 23. [Epub ahead of print]

May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ. Lymph Node Density Affects Cancer-Specific Survival in Patients with Lymph Node-Positive Urothelial Bladder Cancer Following Radical Cystectomy. Eur Urol. 2011 Jan 28. [Epub ahead of print]

May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ. Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node-Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.  Ann Surg Oncol. 2011 Jan 19. [Epub ahead of print]

May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS,Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkam A, Roigas J, Zacharias M, Gunia S, Fritsche HM. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scand J Urol Nephrol. 2011 Mar 10. [Epub ahead of print]

May M, Brookman-May S, Weißbach L, Herbst H, Gilfrich C, Papadopoulos T, Roigas J, Hofstädter F, Wieland WF, Burger M. Solitary mm) apical positive surgical margins are related to biochemical?and  small (?3 recurrence after radical prostatectomy. Int J Urol. 2011 Feb 22. doi: 10.1111/j.1442-2042.2011.02736.x. [Epub ahead of print]